Stock Information
Nuvation Bio Inc (NUVB)
Ticker Symbol: NUVB
Exchange: NYSE
Sector: N/A
Market Cap: $2,751.87 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -0.6398
Revenue (TTM): $0.08 M
Dividend Yield: N/A%
ROE: -54.99%
Latest News
-
Forecasting The Future: 9 Analyst Projections For Nuvation Bio
Tue, Feb 10, 2026 3:00 PM
-
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $11 Price Target
Tue, Feb 10, 2026 10:37 AM
-
Nuvation Bio Announces Pivotal Global Phase 3 SIGMA Trial (G203) for Safusidenib in IDH1-Mutant Glioma
Mon, Feb 9, 2026 1:00 PM
-
Nuvation Bio Finalizes Protocol Amendment To Its Current Global SIGMA Trial Of Safusidenib To Also Enroll Non-Pivotal Single-Arm Group
Mon, Feb 9, 2026 9:05 AM
Key Financials
Financial data not available
